Article Details
Retrieved on: 2017-12-16 23:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>ITUS Corporation funds, develops, acquires, and licenses <b>emerging technologies</b> in the areas of biotechnology. The company has market cap of $44.54 million. The company, through its subsidiary, Anixa Diagnostics Corporation, is developing a platform called Cchek, a series of non-invasive, blood ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here